Natco Pharma Ltd
Amresh T. has worked as the Head of Legal at NATCO Pharma since September 2022. Prior to that, they worked as a Senior Legal Counsel at Emcure Pharmaceuticals Limited from January 2019 to September 2022. Amresh also has experience as a Legal Counsel at Reliance Industries Limited from August 2010 to December 2018.
Amresh T. obtained a Bachelor of Laws (LL.B.) degree from CSJM University, where they studied from 2007 to 2010. Prior to that, they earned a Bachelor of Science (B.Sc.) degree in Chemistry from the same university, studying from 2003 to 2006. Amresh completed their schooling at Kendriya Vidyalaya from 1991 to 2003. In addition to their formal education, they have also obtained several certifications, including the UNCITRAL Mediation Framework Certification from UNCITRAL, the Manupatra Certified Professional (MCP) from Manupatra, the Certificate in Securities Laws from the National Institute of Securities Markets (NISM), the Diploma in Cyber Law from the Asian School of Cyber Laws, the Post Graduate Diploma in Human Rights from the Indian Institute of Human Rights (IIHR), the Brown Belt in Unarmed Combat (Judo-Karate) from the World Goju-Ryu Karate Federation, and the NCC 'C' Certificate from the Indian Army.
This person is not in any offices
Natco Pharma Ltd
2 followers
Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.